• Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act.

Duration: February 1, 2020 to present

General Issues: Health Issues, Pharmacy, Budget/Appropriations

Spending: about $420,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2020: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Executive Office of the President (EOP), Drug Enforcement Administration (DEA), Justice - Dept of (DOJ), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Office of Management & Budget (OMB)